Breast Surgery — Incidental Classic Lobular Carcinoma in Situ
A 38-year-old woman had excision of a 2 cm left breast lump that imaging and core biopsy showed to be a fibroadenoma. Final histopathology confirms the fibroadenoma, with a single incidental focus of classic lobular carcinoma in situ close to the margin. There is no invasive carcinoma, ductal carcinoma in situ or atypia elsewhere. Her bilateral mammogram is normal. What is the most appropriate management?
- A.High-risk surveillance with risk-reducing endocrine counsellingCorrect
- B.Re-excision of the cavity to obtain clear margins
- C.Adjuvant whole-breast radiotherapy
- D.Bilateral risk-reducing mastectomy
Explanation
Classic lobular carcinoma in situ is a marker of increased risk rather than a direct precursor that must be removed. It confers a risk of invasive cancer of roughly 1 to 2% per year (about 30% over 20 to 25 years), spread across both breasts and often of ductal type, so treatment is aimed at the woman rather than the excision site. When it is found incidentally at excision with no other high-risk lesion, no further surgery is needed, and margin status does not matter. Management is enhanced surveillance with annual mammography, regular clinical review and consideration of supplemental magnetic resonance imaging, plus counselling about endocrine risk reduction with tamoxifen in premenopausal women, which roughly halves the risk. Re-excision is the strongest competitor because surgeons are used to clearing margins for ductal carcinoma in situ, but this does not apply to the classic form. Radiotherapy has no role, and bilateral mastectomy is an option only for selected women with additional risk such as a BRCA mutation or strong family history. The exception is pleomorphic or florid lobular carcinoma in situ, which behaves more like ductal carcinoma in situ and is excised to clear margins.
Why each option
- A.
- Correct. Classic lobular carcinoma in situ is a bilateral risk marker, managed with surveillance and counselling about tamoxifen rather than further surgery.
- B.
- Clear margins are not needed for classic lobular carcinoma in situ; re-excision applies to pleomorphic or florid variants and ductal carcinoma in situ.
- C.
- Radiotherapy does not reduce the diffuse, bilateral risk conferred by classic lobular carcinoma in situ and is not indicated.
- D.
- Bilateral mastectomy is reserved for selected women with additional risk such as a BRCA mutation, not isolated classic lobular carcinoma in situ.
Reference: NCCN Guidelines Breast Cancer Risk Reduction v1.2025; American Society of Breast Surgeons consensus on management of lobular carcinoma in situ; UpToDate — Lobular carcinoma in situ and atypical lobular hyperplasia
This is one of 3,306 questions in the MedBoardSA SMLE bank, with timed test mode, tutor mode, and progress tracking by topic.
Practise the full bank